FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911871569> ?p ?o ?g. }

• W2911871569 endingPage "469" @default.
• W2911871569 startingPage "462" @default.
• W2911871569 abstract "Immune checkpoint inhibitors have been successful across several tumor types; however, their efficacy has been uncommon and unpredictable in glioblastomas (GBM), where <10% of patients show long-term responses. To understand the molecular determinants of immunotherapeutic response in GBM, we longitudinally profiled 66 patients, including 17 long-term responders, during standard therapy and after treatment with PD-1 inhibitors (nivolumab or pembrolizumab). Genomic and transcriptomic analysis revealed a significant enrichment of PTEN mutations associated with immunosuppressive expression signatures in non-responders, and an enrichment of MAPK pathway alterations (PTPN11, BRAF) in responders. Responsive tumors were also associated with branched patterns of evolution from the elimination of neoepitopes as well as with differences in T cell clonal diversity and tumor microenvironment profiles. Our study shows that clinical response to anti-PD-1 immunotherapy in GBM is associated with specific molecular alterations, immune expression signatures, and immune infiltration that reflect the tumor's clonal evolution during treatment." @default.
• W2911871569 created "2019-02-21" @default.
• W2911871569 creator A5000121461 @default.
• W2911871569 creator A5000331677 @default.
• W2911871569 creator A5009670051 @default.
• W2911871569 creator A5011704957 @default.
• W2911871569 creator A5023153659 @default.
• W2911871569 creator A5024811283 @default.
• W2911871569 creator A5025845208 @default.
• W2911871569 creator A5029952866 @default.
• W2911871569 creator A5040042276 @default.
• W2911871569 creator A5043535417 @default.
• W2911871569 creator A5044234066 @default.
• W2911871569 creator A5046673359 @default.
• W2911871569 creator A5048705206 @default.
• W2911871569 creator A5050603971 @default.
• W2911871569 creator A5055848888 @default.
• W2911871569 creator A5056128255 @default.
• W2911871569 creator A5057263352 @default.
• W2911871569 creator A5058473872 @default.
• W2911871569 creator A5060074956 @default.
• W2911871569 creator A5060408739 @default.
• W2911871569 creator A5063392722 @default.
• W2911871569 creator A5063573275 @default.
• W2911871569 creator A5066080208 @default.
• W2911871569 creator A5075267004 @default.
• W2911871569 creator A5078069424 @default.
• W2911871569 creator A5079973052 @default.
• W2911871569 creator A5087754052 @default.
• W2911871569 date "2019-02-11" @default.
• W2911871569 modified "2023-10-16" @default.
• W2911871569 title "Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma" @default.
• W2911871569 cites W1940241680 @default.
• W2911871569 cites W1982488143 @default.
• W2911871569 cites W2000305183 @default.
• W2911871569 cites W2013090484 @default.
• W2911871569 cites W2026890342 @default.
• W2911871569 cites W2030259772 @default.
• W2911871569 cites W2039123767 @default.
• W2911871569 cites W2049553585 @default.
• W2911871569 cites W2055696475 @default.
• W2911871569 cites W2073135247 @default.
• W2911871569 cites W2089041106 @default.
• W2911871569 cites W2092772483 @default.
• W2911871569 cites W2096287682 @default.
• W2911871569 cites W2097539142 @default.
• W2911871569 cites W2103441770 @default.
• W2911871569 cites W2109816625 @default.
• W2911871569 cites W2124736921 @default.
• W2911871569 cites W2124887618 @default.
• W2911871569 cites W2125493895 @default.
• W2911871569 cites W2125616358 @default.
• W2911871569 cites W2130410032 @default.
• W2911871569 cites W2130430382 @default.
• W2911871569 cites W2138207763 @default.
• W2911871569 cites W2143163879 @default.
• W2911871569 cites W2152061559 @default.
• W2911871569 cites W2158969445 @default.
• W2911871569 cites W2159707944 @default.
• W2911871569 cites W2162259262 @default.
• W2911871569 cites W2162643152 @default.
• W2911871569 cites W2169456326 @default.
• W2911871569 cites W2170490448 @default.
• W2911871569 cites W2196159484 @default.
• W2911871569 cites W2201214180 @default.
• W2911871569 cites W2201379305 @default.
• W2911871569 cites W2214699570 @default.
• W2911871569 cites W2256496883 @default.
• W2911871569 cites W2289851792 @default.
• W2911871569 cites W2299181842 @default.
• W2911871569 cites W2337209831 @default.
• W2911871569 cites W2410468716 @default.
• W2911871569 cites W2508297861 @default.
• W2911871569 cites W2531876842 @default.
• W2911871569 cites W2551911481 @default.
• W2911871569 cites W2560367415 @default.
• W2911871569 cites W2572174216 @default.
• W2911871569 cites W2574604975 @default.
• W2911871569 cites W2587048937 @default.
• W2911871569 cites W2591493010 @default.
• W2911871569 cites W2610774430 @default.
• W2911871569 cites W2739998491 @default.
• W2911871569 cites W2764040657 @default.
• W2911871569 cites W2774712455 @default.
• W2911871569 cites W2774875527 @default.
• W2911871569 cites W2782124401 @default.
• W2911871569 cites W2788422234 @default.
• W2911871569 cites W2794080875 @default.
• W2911871569 cites W2883808647 @default.
• W2911871569 cites W2951880440 @default.
• W2911871569 cites W4250310729 @default.
• W2911871569 doi "https://doi.org/10.1038/s41591-019-0349-y" @default.
• W2911871569 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6810613" @default.
• W2911871569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30742119" @default.
• W2911871569 hasPublicationYear "2019" @default.
• W2911871569 type Work @default.
• W2911871569 sameAs 2911871569 @default.
• W2911871569 citedByCount "509" @default.

• next